Familial Mediterranean Fever (FMF ) Completed Phase 2 Trials for Canakinumab (DB06168)

Also known as: Familial Mediterranean Fever / Familial Mediterranean Fever (FMF) / Periodic fever / Familial recurrent polyserositis

IndicationStatusPhase
DBCOND0067538 (Familial Mediterranean Fever (FMF ))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01088880Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean FeverTreatment